Skip to main content

24 publications

Name Date Type Actions

Buyback programs - November 2023

Monthly communication regarding buyback programs

04/12/2023 Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

03/12/2023 Description of buyback programs

Buyback programs - october 2023

Monthly communication regarding buyback programs

06/11/2023 Description of buyback programs

Sales 3rd quarter 2023: 136M€

The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories.

26/10/2023 Public releases

Buyback programs - September 2023 (french)

Monthly communication regarding buyback programs

04/10/2023 Description of buyback programs

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet".

13/09/2023 Press releases communication

Buyback programs - August 2023 (french)

Monthly communication regarding buyback programs

12/09/2023 Description of buyback programs

2023 HALF-YEAR RESULTS

Sales: €256m (-5.4% as reported)
Essentials products sales: €151m (59% of Group sales)
Net income - Group share: €32m (12.6% of sales)
EBITDA*: €54m (20.9% of sales)
Cash-flow generation: €31m

07/09/2023 Public releases

Buyback programs - July

Monthly communication regarding buyback programs 
 

22/08/2023 Description of buyback programs

Mastaplex and Vetoquinol announce distribution agreement

Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest..

27/07/2023 Press releases communication